Keith Regnante's Net Worth
Keith Regnante's net worth is estimated to be at least $2,594,684.60 as of 11/09/2024. CoreStreet's estimation of Keith Regnante's net worth is based on their sale of stock and current holding of stock.
Keith Regnante is CFO at Keros Therapeutics Inc. They have executed at least 3 trades of stock as per SEC Form 4 filings. Their most recent trade was for 20,000 units of KROS stock on 06/08/2023. Their biggest sale was on 09/24/2018 when they sold 29,500 units of Wave Life Sciences Ltd stock for $1,622,500.00. They typically trade 1 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $2,594,684.60
Most recent insider trade:
- June 8, 2023
Keith Regnante's Insider Trading History
| Keros Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 8, 2023 | CFO | 20,000 | $47.79 | Sell | $955,800.00 |
| Wave Life Sciences Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 24, 2018 | CFO | 29,500 | $55.00 | Sell | $1,622,500.00 |
Feb. 16, 2018 | CFO | 316 | $51.85 | Sell | $16,384.60 |